Why big Medicare Advantage insurers may root for Biden to lose in 2024

In This Article:

Insurance giants have a bigger stake in this year’s presidential election after recent moves by the Biden administration cut into the profitability of Medicare Advantage plans.

In the last week, the Centers for Medicare and Medicaid Services (CMS) delivered consecutive blows to the industry that offers these private-sector Medicare alternatives, denting insurance stocks and pulling down estimates of future earnings.

Insurers will get paid less than expected next year for providing these plans, while, at the same time, they must abide by new, and probably costlier, regulations. Other key changes rolling out over the next three years could also nick their bottom lines.

The industry expects a second term for President Joe Biden would bring more of the same at a time when the youngest baby boomers become Medicare-eligible and more of the older ones seek healthcare services.

"Do I want to say it's a historic level of regulations? If it's not, it's got to be close to it," Whit Mayo, an analyst with Leerink Partners, told Yahoo Finance. "Biden is no friend to the industry right now."

FILE - This Nov. 8, 2018 file photo shows a page from the 2019 U.S. Medicare Handbook in Washington. Medicare open enrollment starts soon, but 7 in 10 Medicare beneficiaries say they don’t compare Medicare plans during this period, which stretches from Oct. 15 to Dec. 7, 2022.  (AP Photo/Pablo Martinez Monsivais, File)
This Nov. 8, 2018 file photo shows a page from the 2019 U.S. Medicare Handbook in Washington. (AP Photo/Pablo Martinez Monsivais, File) · ASSOCIATED PRESS

'A major change'

The new regulations have come hard and fast recently.

Last week, the government said it would increase its payments to Medicare Advantage (MA) insurers by 3.7% in 2025. That’s "marginally worse" than the earlier proposed rate, Mayo said, and “inconsistent with almost any historic precedent.”

It also caught the industry by surprise because many expected CMS to incorporate the uptick in healthcare service volumes in the fourth quarter.

A few days later, CMS finalized other rules around health equity, behavioral healthcare services, and supplemental benefits that would require more action from insurers.

The agency also established new rules on how much insurers can compensate a broker selling Medicare Advantage plans to ensure seniors are steered into plans that best meet their needs — not into ones that are most profitable.

“CMS does not want an agent to have preference over any plan based on commissions…so this is a major change,” Mayo said.

FILE - In this June 8, 2015, file photo specialist Anthony Rinaldi works adjacent to the post that handles Humana, on the floor of the New York Stock Exchange. Humana is adding two more independent directors to its board under an agreement with activist hedge fund Starboard Value. The Medicare Advantage coverage provider said Tuesday, Feb. 22, 2022, that it will add one director before the company’s annual shareholder meeting April 22 and the other afterward. (AP Photo/Richard Drew, File)
In this June 8, 2015, file photo specialist Anthony Rinaldi works adjacent to the post that handles Humana, on the floor of the New York Stock Exchange. (AP Photo/Richard Drew, File) · ASSOCIATED PRESS

These efforts are weighing down insurer stocks.

Year to date, shares of Humana (HUM) — which has the largest exposure with MA accounts making up 77% of its total revenue — are down 30%.

The stock of UnitedHealthcare (UNH) has declined nearly 13% since the beginning of the year. MA accounts make up 31% of UnitedHealthcare's total revenue, according to Ann Hynes, managing director at Mizuho Americas.

In a note last week to investors, Hynes estimated the 3.7% increase in the MA payment rate could be a 2% and 4% "headwind" for UnitedHealthcare’s 2025 earnings, a 2% to 6% drag on both CVS Healthcare Corp.’s (CVS) and Centene Corp.’s (CNC) profits, and an 8% anchor on Humana’s bottom line.